Olympus Announces FDA Clearance of RenaFlex™, Its First Single-use Flexible Ureteroscope
Posted:
Olympus Corporation single-use flexible ureteroscopy system, RenaFlex™, has received clearance from the U.S. Food and Drug Administration (FDA) and will soon be available in the United States.
This product assists in the diagnosis and treatment of urological conditions such as #Urolithiasis.
The rapid evolution of artificial intelligence (AI) offers transformative opportunities in healthcare. However, to fully realise this potential, it is important to build strong foundations in education and research.
Read the full article here.
It is important the UK keeps control of NHS data in order to protect patients, Prime Minister Sir Keir Starmer has said, as he insisted it was also important companies can make use of it.
Read the full article here.
Attendees
Sponsors and Exhibitors
AI Training for Doctors Workshops
Contact us